Skip to main content
. 2017 Apr 20;17:289. doi: 10.1186/s12879-017-2390-0

Table 2.

Distribution of FcγRIIA-131Arg/His, FcγRIIIA-176F/V and FcγRIIIB-NA1/NA2 genotypes within the study groups

N (%) with genotype in groupa HWE, P-value
(SMA + non-SMA) c
Genotypes SMA
(Hb < 6.0 g/dL)
(n = 114)
Non-SMA
(Hb ≥ 6.0 g/dL)
(n = 160)
P-value b
FcγRIIA-131Arg/His
 Arg/Arg, n (%) 30 (26.3) 39 (24.3)
 Arg/His n (%) 59 (51.8) 71 (44.4) 0.226b 0.402b
 His/His, n (%) 25 (21.9) 50 (31.3)
 X(His) = 0.48
FcγRIIIA-176 F/V
 FF, n (%) 61 (53.5) 77 (48.1)
 FV, n (%) 45 (39.5) 60 (37.5) 0.162b 0.113b
 VV, n (%) 8 (7.0) 23 (14.4)
 X(V) = 0.30
FcγRIIIB-NA1/NA2
 NA1/NA1 6 (5.3) 8 (5.0)
 NA1/NA2 73 (64.0) 94 (58.8) 0.632b <0.001 b
 NA2/NA2 35 (30.7) 58 (36.2)
 X(NA1) = 0.36

aData are presented as n (%) of children. Children with parasitemia were categorized on the basis of presence or absence of severe malarial anemia SMA based (defined as Hb < 6.0 g/dL, with any density parasitemia). bStatistical significance determined by χ2 analysis. X; the overall minor allele frequency in the study population. c HWE Hardy-Weinberg Equilibrium

Values in bold are significant p-values at a cut-off of p≤0.05